nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A risk balancing act – Tourism competition using health leverage in the COVID-19 era
|
Grech, Victor |
|
|
31 |
3 |
p. 121-130 |
artikel |
2 |
Does COVID-19 teach us anything for our future?
|
Ralph Edwards, Ivor |
|
|
31 |
3 |
p. 107-109 |
artikel |
3 |
Dogs bark, but the caravan goes on: A discussion on the meta-analysis of antidepressants by Andrea Cipriani et al.
|
Makovec, Tomaž |
|
|
31 |
3 |
p. 149-155 |
artikel |
4 |
Inadequate evaluation of potential side effects of sildenafil in preterm stopped Dutch trial
|
Bijl, Dick |
|
|
31 |
3 |
p. 145-148 |
artikel |
5 |
In reply to: Presentation of benefits and harms of antidepressants on websites: A cross sectional study
|
Gossell-Williams, Maxine |
|
|
31 |
3 |
p. 131-132 |
artikel |
6 |
Patient safety issues associated with the use of compounded medicines as alternatives to approved pharmaceutical products in Europe and how best practice can improve outcomes
|
Isles, Mike |
|
|
31 |
3 |
p. 133-144 |
artikel |
7 |
Pharmaceutical cost analysis of dental diseases: An Indian scenario
|
Talreja, Pankaj |
|
|
31 |
3 |
p. 165-177 |
artikel |
8 |
Risk of using hydroxychloroquine as a treatment of COVID-19
|
Alanagreh, Lo’ai |
|
|
31 |
3 |
p. 111-116 |
artikel |
9 |
Some reflections on organizational profiles in Italy in the time of COVID-19
|
Bottari, Carlo |
|
|
31 |
3 |
p. 117-119 |
artikel |
10 |
What have antidepressants been tested for? A systematic review
|
Gøtzsche, Peter C. |
|
|
31 |
3 |
p. 157-163 |
artikel |